Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 61 | 2021 | 11206 | 3.460 |
Why?
|
Prostate | 23 | 2020 | 1781 | 2.900 |
Why?
|
Urinary Bladder Neoplasms | 26 | 2020 | 2254 | 2.820 |
Why?
|
Kidney Neoplasms | 21 | 2020 | 4299 | 2.160 |
Why?
|
Prostatectomy | 16 | 2019 | 1840 | 1.910 |
Why?
|
Carcinoma, Renal Cell | 16 | 2020 | 3198 | 1.770 |
Why?
|
Urinary Bladder | 7 | 2019 | 1160 | 1.280 |
Why?
|
Urogenital Neoplasms | 2 | 2020 | 133 | 1.140 |
Why?
|
Adenocarcinoma | 17 | 2020 | 6400 | 1.080 |
Why?
|
Urethral Neoplasms | 2 | 2020 | 37 | 1.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2020 | 8636 | 1.060 |
Why?
|
Carcinoma, Transitional Cell | 7 | 2019 | 798 | 0.990 |
Why?
|
Cystectomy | 7 | 2019 | 644 | 0.980 |
Why?
|
Prostate-Specific Antigen | 15 | 2019 | 2483 | 0.900 |
Why?
|
Prognosis | 43 | 2020 | 30031 | 0.890 |
Why?
|
Neoplasm Staging | 14 | 2020 | 11249 | 0.860 |
Why?
|
Occupational Therapy | 2 | 2023 | 142 | 0.840 |
Why?
|
MicroRNAs | 7 | 2019 | 3806 | 0.790 |
Why?
|
Disease Progression | 21 | 2019 | 13643 | 0.670 |
Why?
|
Aromatase | 3 | 2020 | 147 | 0.650 |
Why?
|
Prostatic Hyperplasia | 9 | 2020 | 523 | 0.640 |
Why?
|
Succinate Dehydrogenase | 2 | 2018 | 148 | 0.610 |
Why?
|
Activities of Daily Living | 6 | 2022 | 2433 | 0.600 |
Why?
|
Cushing Syndrome | 3 | 2010 | 241 | 0.600 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 5 | 2020 | 74 | 0.590 |
Why?
|
Calcium Signaling | 3 | 2019 | 737 | 0.590 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2017 | 287 | 0.590 |
Why?
|
Adenoma, Oxyphilic | 2 | 2020 | 152 | 0.590 |
Why?
|
Male | 137 | 2024 | 364761 | 0.580 |
Why?
|
Myosin-Light-Chain Phosphatase | 1 | 2017 | 21 | 0.570 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 89 | 0.570 |
Why?
|
Physical Therapy Modalities | 5 | 2019 | 533 | 0.570 |
Why?
|
Neoplasm Invasiveness | 15 | 2021 | 3637 | 0.560 |
Why?
|
Hydrogen | 1 | 2017 | 172 | 0.540 |
Why?
|
Immunohistochemistry | 15 | 2019 | 11139 | 0.530 |
Why?
|
Magnetic Resonance Spectroscopy | 10 | 2019 | 3783 | 0.530 |
Why?
|
Biopsy | 11 | 2019 | 6816 | 0.500 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2015 | 103 | 0.490 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2018 | 9425 | 0.490 |
Why?
|
Disulfides | 1 | 2017 | 467 | 0.490 |
Why?
|
Apoptosis | 12 | 2020 | 9526 | 0.490 |
Why?
|
Scleroderma, Systemic | 1 | 2019 | 349 | 0.480 |
Why?
|
Keratinocytes | 4 | 2019 | 879 | 0.480 |
Why?
|
Hematuria | 2 | 2013 | 233 | 0.480 |
Why?
|
Humans | 170 | 2024 | 768369 | 0.470 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2006 | 161 | 0.460 |
Why?
|
Lymphatic Metastasis | 3 | 2020 | 2930 | 0.450 |
Why?
|
Muscle, Smooth | 3 | 2016 | 930 | 0.450 |
Why?
|
Cell Proliferation | 18 | 2020 | 10490 | 0.430 |
Why?
|
Aged | 66 | 2022 | 171514 | 0.430 |
Why?
|
Cadmium | 2 | 2013 | 216 | 0.430 |
Why?
|
Middle Aged | 73 | 2021 | 223406 | 0.430 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1147 | 0.420 |
Why?
|
Carcinoma, Ductal | 1 | 2013 | 97 | 0.420 |
Why?
|
Ultrasonography, Interventional | 1 | 2021 | 1520 | 0.420 |
Why?
|
Metabolomics | 6 | 2019 | 1675 | 0.410 |
Why?
|
RNA Interference | 5 | 2017 | 2832 | 0.400 |
Why?
|
Taiwan | 9 | 2020 | 528 | 0.400 |
Why?
|
Penile Neoplasms | 1 | 2014 | 165 | 0.400 |
Why?
|
Upper Extremity | 5 | 2019 | 683 | 0.400 |
Why?
|
Urothelium | 3 | 2020 | 275 | 0.390 |
Why?
|
Carcinoma, Small Cell | 2 | 2015 | 420 | 0.390 |
Why?
|
Cell Line, Tumor | 21 | 2020 | 17149 | 0.390 |
Why?
|
Survival Rate | 13 | 2020 | 12875 | 0.380 |
Why?
|
Disease-Free Survival | 11 | 2019 | 6856 | 0.380 |
Why?
|
Angiomyolipoma | 4 | 2020 | 188 | 0.380 |
Why?
|
Kaplan-Meier Estimate | 12 | 2018 | 6537 | 0.370 |
Why?
|
Diagnosis, Differential | 12 | 2020 | 13025 | 0.370 |
Why?
|
Urethra | 2 | 2016 | 406 | 0.370 |
Why?
|
Racemases and Epimerases | 4 | 2004 | 114 | 0.370 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2017 | 3520 | 0.370 |
Why?
|
Stroke | 11 | 2019 | 9790 | 0.370 |
Why?
|
Receptors, Androgen | 8 | 2018 | 1084 | 0.350 |
Why?
|
Lymphangioleiomyomatosis | 3 | 2019 | 208 | 0.350 |
Why?
|
Membrane Proteins | 6 | 2020 | 7895 | 0.350 |
Why?
|
Reactive Oxygen Species | 8 | 2020 | 2150 | 0.350 |
Why?
|
Movement | 1 | 2017 | 1489 | 0.340 |
Why?
|
Oxidative Stress | 4 | 2018 | 3145 | 0.340 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1136 | 0.330 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2015 | 733 | 0.330 |
Why?
|
Tuberous Sclerosis | 2 | 2014 | 1040 | 0.330 |
Why?
|
Osteoporosis | 2 | 2017 | 1606 | 0.330 |
Why?
|
Leuprolide | 1 | 2011 | 313 | 0.330 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 2643 | 0.330 |
Why?
|
Genes, Tumor Suppressor | 1 | 2014 | 1064 | 0.330 |
Why?
|
Dermatitis, Atopic | 1 | 2017 | 734 | 0.330 |
Why?
|
DNA Methylation | 9 | 2020 | 4425 | 0.330 |
Why?
|
Paresis | 4 | 2019 | 177 | 0.330 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1121 | 0.320 |
Why?
|
Cell Movement | 8 | 2018 | 5223 | 0.320 |
Why?
|
Tumor Suppressor Proteins | 7 | 2016 | 2819 | 0.310 |
Why?
|
Feedback, Sensory | 2 | 2019 | 58 | 0.310 |
Why?
|
Ureteral Neoplasms | 1 | 2009 | 108 | 0.310 |
Why?
|
Neoplastic Cells, Circulating | 5 | 2018 | 958 | 0.310 |
Why?
|
RNA, Messenger | 13 | 2020 | 12813 | 0.300 |
Why?
|
Paraneoplastic Syndromes | 1 | 2010 | 155 | 0.300 |
Why?
|
Acetyltransferases | 2 | 2010 | 231 | 0.300 |
Why?
|
Kidney Pelvis | 1 | 2009 | 195 | 0.300 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2020 | 413 | 0.300 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3939 | 0.300 |
Why?
|
Androstenes | 2 | 2020 | 186 | 0.290 |
Why?
|
Laparoscopy | 3 | 2013 | 2056 | 0.290 |
Why?
|
Stromal Cells | 5 | 2020 | 1335 | 0.280 |
Why?
|
Hysterectomy, Vaginal | 1 | 2006 | 28 | 0.280 |
Why?
|
Androgen Antagonists | 3 | 2015 | 1418 | 0.280 |
Why?
|
Proportional Hazards Models | 9 | 2018 | 12561 | 0.280 |
Why?
|
Dextromethorphan | 1 | 2006 | 37 | 0.280 |
Why?
|
Ureter | 1 | 2009 | 370 | 0.280 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2011 | 555 | 0.270 |
Why?
|
Cyclins | 3 | 2007 | 606 | 0.270 |
Why?
|
Signal Transduction | 16 | 2019 | 23639 | 0.270 |
Why?
|
Diagnostic Imaging | 5 | 2018 | 3543 | 0.270 |
Why?
|
Neoplasm Metastasis | 7 | 2019 | 4931 | 0.270 |
Why?
|
Tissue Array Analysis | 3 | 2018 | 551 | 0.260 |
Why?
|
Ketorolac | 1 | 2006 | 95 | 0.260 |
Why?
|
Bone Neoplasms | 3 | 2019 | 2562 | 0.260 |
Why?
|
Adrenocortical Carcinoma | 1 | 2006 | 88 | 0.260 |
Why?
|
Gastroenteritis | 2 | 2020 | 236 | 0.260 |
Why?
|
Anemia | 1 | 2015 | 1521 | 0.250 |
Why?
|
Female | 68 | 2024 | 396926 | 0.250 |
Why?
|
Nuclear Receptor Coactivators | 2 | 2017 | 60 | 0.240 |
Why?
|
Kidney | 3 | 2018 | 7064 | 0.240 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4613 | 0.240 |
Why?
|
Adrenocortical Adenoma | 1 | 2005 | 46 | 0.240 |
Why?
|
Stevens-Johnson Syndrome | 2 | 2018 | 246 | 0.240 |
Why?
|
Movement Disorders | 1 | 2008 | 464 | 0.240 |
Why?
|
Retrospective Studies | 25 | 2023 | 81835 | 0.230 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2006 | 259 | 0.230 |
Why?
|
Radiation Injuries | 2 | 2016 | 1205 | 0.230 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2004 | 81 | 0.230 |
Why?
|
Gene Expression Profiling | 9 | 2019 | 9508 | 0.230 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 2020 | 112 | 0.220 |
Why?
|
Incidental Findings | 2 | 2019 | 699 | 0.220 |
Why?
|
Aged, 80 and over | 23 | 2020 | 59679 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2018 | 3619 | 0.220 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2882 | 0.220 |
Why?
|
Adult | 42 | 2024 | 223528 | 0.220 |
Why?
|
Brachytherapy | 1 | 2011 | 1227 | 0.210 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2009 | 664 | 0.210 |
Why?
|
Pheochromocytoma | 1 | 2005 | 328 | 0.210 |
Why?
|
Urologic Neoplasms | 2 | 2020 | 319 | 0.210 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2011 | 1536 | 0.210 |
Why?
|
Survival Analysis | 5 | 2019 | 10127 | 0.210 |
Why?
|
Carcinoma, Papillary | 2 | 2020 | 792 | 0.200 |
Why?
|
Cadherins | 3 | 2017 | 906 | 0.200 |
Why?
|
Adrenal Glands | 1 | 2005 | 557 | 0.200 |
Why?
|
Parotid Diseases | 1 | 2002 | 49 | 0.200 |
Why?
|
Histiocytosis, Sinus | 1 | 2002 | 44 | 0.200 |
Why?
|
Cell Cycle | 4 | 2018 | 2942 | 0.200 |
Why?
|
Telepathology | 2 | 2014 | 77 | 0.200 |
Why?
|
Mass Spectrometry | 3 | 2017 | 2204 | 0.200 |
Why?
|
Lymphoproliferative Disorders | 2 | 2002 | 531 | 0.190 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12096 | 0.190 |
Why?
|
Disability Evaluation | 6 | 2020 | 1839 | 0.190 |
Why?
|
Immunoenzyme Techniques | 5 | 2014 | 1706 | 0.190 |
Why?
|
Chemotherapy, Adjuvant | 7 | 2019 | 3550 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2015 | 2465 | 0.180 |
Why?
|
Postural Balance | 2 | 2020 | 638 | 0.180 |
Why?
|
Dental Caries | 1 | 2024 | 429 | 0.180 |
Why?
|
Risk Assessment | 4 | 2018 | 24310 | 0.180 |
Why?
|
Time and Motion Studies | 1 | 2020 | 143 | 0.180 |
Why?
|
Alternative Splicing | 1 | 2005 | 1094 | 0.180 |
Why?
|
Receptors, CCR8 | 1 | 2020 | 28 | 0.180 |
Why?
|
Glycerolphosphate Dehydrogenase | 1 | 2020 | 40 | 0.180 |
Why?
|
Tumor Burden | 3 | 2015 | 1909 | 0.180 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 37 | 0.170 |
Why?
|
Home Health Aides | 1 | 2020 | 16 | 0.170 |
Why?
|
Glycerophosphates | 1 | 2020 | 50 | 0.170 |
Why?
|
Caliciviridae Infections | 1 | 2020 | 29 | 0.170 |
Why?
|
Metformin | 2 | 2020 | 914 | 0.170 |
Why?
|
Norovirus | 1 | 2020 | 37 | 0.170 |
Why?
|
Loss of Heterozygosity | 5 | 2016 | 663 | 0.170 |
Why?
|
Remote Consultation | 2 | 2014 | 242 | 0.170 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2005 | 736 | 0.170 |
Why?
|
Watchful Waiting | 2 | 2015 | 496 | 0.170 |
Why?
|
COUP Transcription Factor II | 1 | 2019 | 19 | 0.170 |
Why?
|
Promoter Regions, Genetic | 8 | 2020 | 5803 | 0.160 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2015 | 4083 | 0.160 |
Why?
|
Phosphoproteins | 2 | 2005 | 2450 | 0.160 |
Why?
|
TRPC Cation Channels | 1 | 2019 | 111 | 0.160 |
Why?
|
Spermatocele | 1 | 2018 | 10 | 0.160 |
Why?
|
Chemokines, CC | 1 | 2020 | 285 | 0.160 |
Why?
|
Exercise Therapy | 3 | 2017 | 941 | 0.160 |
Why?
|
Robotics | 2 | 2019 | 826 | 0.160 |
Why?
|
Lactate Dehydrogenases | 1 | 2018 | 26 | 0.160 |
Why?
|
Colonic Neoplasms | 2 | 2013 | 2544 | 0.160 |
Why?
|
Pathology, Clinical | 2 | 2014 | 377 | 0.160 |
Why?
|
Estradiol | 2 | 2017 | 1948 | 0.150 |
Why?
|
Hemangiopericytoma | 1 | 2018 | 71 | 0.150 |
Why?
|
Hyphae | 1 | 2018 | 52 | 0.150 |
Why?
|
Indomethacin | 1 | 2019 | 323 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4582 | 0.150 |
Why?
|
Cryopreservation | 1 | 2003 | 731 | 0.150 |
Why?
|
Tumor Cells, Cultured | 6 | 2020 | 6135 | 0.150 |
Why?
|
Treatment Outcome | 18 | 2020 | 65408 | 0.150 |
Why?
|
Varicocele | 1 | 2018 | 75 | 0.150 |
Why?
|
Cell Dedifferentiation | 1 | 2019 | 124 | 0.150 |
Why?
|
Skin Aging | 1 | 2019 | 141 | 0.150 |
Why?
|
Mice, Nude | 7 | 2020 | 3635 | 0.150 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 1207 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 36840 | 0.150 |
Why?
|
gamma-Glutamyltransferase | 1 | 2018 | 144 | 0.150 |
Why?
|
Hypertension | 3 | 2010 | 8610 | 0.150 |
Why?
|
RNA-Binding Protein EWS | 1 | 2019 | 211 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2018 | 2964 | 0.150 |
Why?
|
Restraint, Physical | 2 | 2010 | 185 | 0.150 |
Why?
|
Follow-Up Studies | 11 | 2018 | 39429 | 0.150 |
Why?
|
Estrogen Receptor alpha | 2 | 2019 | 582 | 0.140 |
Why?
|
BK Virus | 1 | 2018 | 120 | 0.140 |
Why?
|
Gene Amplification | 2 | 2013 | 1091 | 0.140 |
Why?
|
Transcription Factors | 4 | 2011 | 12176 | 0.140 |
Why?
|
Boston | 6 | 2017 | 9359 | 0.140 |
Why?
|
Age Factors | 6 | 2017 | 18477 | 0.140 |
Why?
|
Boron Compounds | 1 | 2019 | 196 | 0.140 |
Why?
|
Carrier Proteins | 4 | 2014 | 4948 | 0.140 |
Why?
|
Blotting, Western | 6 | 2014 | 5042 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 259 | 0.140 |
Why?
|
Transients and Migrants | 1 | 2020 | 170 | 0.140 |
Why?
|
Cell Growth Processes | 3 | 2020 | 383 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 626 | 0.140 |
Why?
|
STAT3 Transcription Factor | 2 | 2019 | 873 | 0.140 |
Why?
|
Resilience, Psychological | 1 | 2024 | 804 | 0.140 |
Why?
|
PPAR gamma | 2 | 2017 | 487 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11844 | 0.130 |
Why?
|
beta-Globins | 1 | 2017 | 112 | 0.130 |
Why?
|
Polyomavirus Infections | 1 | 2018 | 193 | 0.130 |
Why?
|
Liver Neoplasms | 4 | 2017 | 4362 | 0.130 |
Why?
|
Sirtuin 1 | 1 | 2017 | 247 | 0.130 |
Why?
|
TRPM Cation Channels | 1 | 2017 | 139 | 0.130 |
Why?
|
Base Sequence | 3 | 2019 | 12426 | 0.130 |
Why?
|
Endometrial Neoplasms | 1 | 2005 | 1382 | 0.130 |
Why?
|
Caspase 12 | 1 | 2015 | 8 | 0.130 |
Why?
|
Pain, Postoperative | 1 | 2006 | 1763 | 0.130 |
Why?
|
Mice | 20 | 2020 | 82051 | 0.130 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2018 | 350 | 0.130 |
Why?
|
Drug Labeling | 1 | 2018 | 250 | 0.130 |
Why?
|
Animals | 29 | 2020 | 169424 | 0.130 |
Why?
|
Cerebral Palsy | 2 | 2011 | 478 | 0.130 |
Why?
|
Carbamazepine | 1 | 2016 | 224 | 0.130 |
Why?
|
Leukocyte Disorders | 1 | 2015 | 12 | 0.130 |
Why?
|
Pathology, Surgical | 2 | 2014 | 151 | 0.130 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3611 | 0.130 |
Why?
|
Candidiasis | 1 | 2018 | 367 | 0.130 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 471 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 757 | 0.130 |
Why?
|
Calcium Channel Blockers | 1 | 2019 | 692 | 0.130 |
Why?
|
Reproducibility of Results | 8 | 2020 | 20232 | 0.130 |
Why?
|
Transcription Factor CHOP | 1 | 2015 | 69 | 0.130 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 467 | 0.120 |
Why?
|
Granuloma, Pyogenic | 1 | 2015 | 47 | 0.120 |
Why?
|
HLA-B Antigens | 1 | 2016 | 319 | 0.120 |
Why?
|
Candida albicans | 1 | 2018 | 376 | 0.120 |
Why?
|
Recovery of Function | 6 | 2019 | 2994 | 0.120 |
Why?
|
Phthalazines | 1 | 2018 | 396 | 0.120 |
Why?
|
Testis | 1 | 2018 | 783 | 0.120 |
Why?
|
Dansyl Compounds | 1 | 2014 | 19 | 0.120 |
Why?
|
bcl-Associated Death Protein | 1 | 2015 | 102 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2019 | 635 | 0.120 |
Why?
|
Turbinates | 1 | 2015 | 66 | 0.120 |
Why?
|
ROC Curve | 4 | 2019 | 3623 | 0.120 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 342 | 0.120 |
Why?
|
Cognition | 3 | 2023 | 7062 | 0.120 |
Why?
|
Hydrocortisone | 3 | 2010 | 1836 | 0.120 |
Why?
|
RNA, Neoplasm | 1 | 2018 | 751 | 0.120 |
Why?
|
Nose Diseases | 1 | 2015 | 79 | 0.120 |
Why?
|
Time Factors | 11 | 2019 | 40271 | 0.120 |
Why?
|
Sex Factors | 3 | 2018 | 10647 | 0.120 |
Why?
|
Rotavirus Vaccines | 1 | 2015 | 62 | 0.120 |
Why?
|
In Situ Hybridization | 3 | 2016 | 1906 | 0.120 |
Why?
|
Neurofibromin 1 | 1 | 2016 | 190 | 0.120 |
Why?
|
Imidazoles | 2 | 2019 | 1174 | 0.120 |
Why?
|
Radionuclide Imaging | 2 | 2012 | 1998 | 0.120 |
Why?
|
Adenosine Triphosphate | 2 | 2020 | 2003 | 0.120 |
Why?
|
Androgens | 2 | 2020 | 1285 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 621 | 0.120 |
Why?
|
Protective Agents | 1 | 2015 | 151 | 0.120 |
Why?
|
Herpesvirus 1, Human | 2 | 2010 | 744 | 0.120 |
Why?
|
Rotavirus Infections | 1 | 2015 | 85 | 0.120 |
Why?
|
Cyclopentanes | 1 | 2014 | 87 | 0.120 |
Why?
|
Principal Component Analysis | 3 | 2019 | 949 | 0.120 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 616 | 0.120 |
Why?
|
Disease Models, Animal | 7 | 2020 | 18390 | 0.120 |
Why?
|
Rotavirus | 1 | 2015 | 110 | 0.110 |
Why?
|
Proteus mirabilis | 1 | 2014 | 24 | 0.110 |
Why?
|
Fungal Proteins | 1 | 2018 | 908 | 0.110 |
Why?
|
Gene Rearrangement | 1 | 2019 | 1139 | 0.110 |
Why?
|
Single-Blind Method | 4 | 2019 | 1585 | 0.110 |
Why?
|
Poland | 1 | 2014 | 197 | 0.110 |
Why?
|
Telangiectasis | 1 | 2014 | 78 | 0.110 |
Why?
|
Deoxycytidine | 1 | 2018 | 888 | 0.110 |
Why?
|
SEER Program | 1 | 2019 | 1476 | 0.110 |
Why?
|
Transfection | 5 | 2017 | 5767 | 0.110 |
Why?
|
Risk Factors | 13 | 2020 | 74915 | 0.110 |
Why?
|
Cystitis | 1 | 2014 | 95 | 0.110 |
Why?
|
Cytoskeleton | 1 | 2019 | 1179 | 0.110 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 208 | 0.110 |
Why?
|
Mice, Inbred BALB C | 6 | 2020 | 6241 | 0.110 |
Why?
|
Aromatase Inhibitors | 1 | 2018 | 518 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor B | 1 | 2013 | 25 | 0.110 |
Why?
|
Musculoskeletal Diseases | 1 | 2020 | 601 | 0.110 |
Why?
|
Incidence | 4 | 2017 | 21552 | 0.110 |
Why?
|
Hydrogen Peroxide | 1 | 2017 | 742 | 0.110 |
Why?
|
Skin | 2 | 2019 | 4520 | 0.110 |
Why?
|
Students | 1 | 2023 | 1751 | 0.110 |
Why?
|
Carcinoma | 2 | 2016 | 2341 | 0.110 |
Why?
|
Mitochondria | 4 | 2020 | 3672 | 0.110 |
Why?
|
Models, Anatomic | 1 | 2017 | 684 | 0.110 |
Why?
|
Posterior Horn Cells | 1 | 2013 | 87 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 998 | 0.110 |
Why?
|
Magnetoencephalography | 1 | 2017 | 641 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2017 | 1615 | 0.110 |
Why?
|
Combined Modality Therapy | 6 | 2017 | 8559 | 0.110 |
Why?
|
Predictive Value of Tests | 7 | 2017 | 15459 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2017 | 1170 | 0.110 |
Why?
|
Sciatica | 1 | 2013 | 97 | 0.110 |
Why?
|
Chromatography, Micellar Electrokinetic Capillary | 1 | 2012 | 3 | 0.110 |
Why?
|
3' Untranslated Regions | 1 | 2015 | 514 | 0.110 |
Why?
|
Estrogens | 1 | 2020 | 1531 | 0.110 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2013 | 61 | 0.100 |
Why?
|
Translocation, Genetic | 1 | 2018 | 1395 | 0.100 |
Why?
|
Cohort Studies | 9 | 2021 | 41782 | 0.100 |
Why?
|
Polymethacrylic Acids | 1 | 2012 | 32 | 0.100 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2015 | 462 | 0.100 |
Why?
|
Fibroblasts | 3 | 2019 | 4180 | 0.100 |
Why?
|
Ultrasonography | 4 | 2018 | 5994 | 0.100 |
Why?
|
Penis | 1 | 2014 | 213 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 257 | 0.100 |
Why?
|
Preoperative Period | 1 | 2015 | 564 | 0.100 |
Why?
|
Prostaglandins | 1 | 2014 | 398 | 0.100 |
Why?
|
Oncogenes | 1 | 2018 | 1235 | 0.100 |
Why?
|
Dinoprostone | 2 | 2019 | 597 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2017 | 2331 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1193 | 0.100 |
Why?
|
Pregnancy Complications | 1 | 2006 | 2969 | 0.100 |
Why?
|
Preoperative Care | 2 | 2015 | 2257 | 0.100 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 879 | 0.100 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2019 | 2525 | 0.100 |
Why?
|
Cyclooxygenase 2 | 4 | 2019 | 599 | 0.100 |
Why?
|
Muscle Neoplasms | 1 | 2013 | 130 | 0.100 |
Why?
|
Phylogeny | 1 | 2020 | 2841 | 0.100 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2012 | 410 | 0.100 |
Why?
|
Mutation | 10 | 2018 | 30235 | 0.100 |
Why?
|
Laser Coagulation | 1 | 2014 | 333 | 0.100 |
Why?
|
Down-Regulation | 5 | 2019 | 2942 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2015 | 635 | 0.100 |
Why?
|
Lasers, Solid-State | 1 | 2014 | 183 | 0.100 |
Why?
|
Haploinsufficiency | 1 | 2013 | 336 | 0.100 |
Why?
|
Polyvinyls | 1 | 2012 | 156 | 0.100 |
Why?
|
Bowen's Disease | 1 | 2011 | 13 | 0.100 |
Why?
|
Heat-Shock Proteins | 1 | 2015 | 798 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2015 | 1604 | 0.090 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2011 | 21 | 0.090 |
Why?
|
Wnt Proteins | 1 | 2015 | 724 | 0.090 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1625 | 0.090 |
Why?
|
Calcium | 4 | 2019 | 5793 | 0.090 |
Why?
|
Nephrectomy | 3 | 2017 | 949 | 0.090 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2013 | 440 | 0.090 |
Why?
|
Arsenic Poisoning | 1 | 2011 | 55 | 0.090 |
Why?
|
Motor Activity | 2 | 2019 | 2722 | 0.090 |
Why?
|
Naloxone | 1 | 2013 | 371 | 0.090 |
Why?
|
Psychometrics | 1 | 2020 | 3072 | 0.090 |
Why?
|
Pituitary Gland, Anterior | 1 | 2010 | 142 | 0.090 |
Why?
|
Dilazep | 1 | 2010 | 4 | 0.090 |
Why?
|
Areca | 1 | 2010 | 11 | 0.090 |
Why?
|
Recurrence | 3 | 2014 | 8510 | 0.090 |
Why?
|
Collagen | 1 | 2019 | 2646 | 0.090 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2010 | 17 | 0.090 |
Why?
|
Statistics, Nonparametric | 4 | 2018 | 2861 | 0.090 |
Why?
|
Ornithine Decarboxylase | 1 | 2010 | 63 | 0.090 |
Why?
|
Spermine | 1 | 2010 | 70 | 0.090 |
Why?
|
Cells, Cultured | 5 | 2019 | 19035 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2017 | 825 | 0.090 |
Why?
|
Anticonvulsants | 2 | 2018 | 1923 | 0.090 |
Why?
|
Ribs | 1 | 2012 | 261 | 0.090 |
Why?
|
Diabetes Insipidus | 1 | 2010 | 144 | 0.090 |
Why?
|
Neutrophils | 2 | 2015 | 3790 | 0.090 |
Why?
|
Dipyridamole | 1 | 2010 | 143 | 0.090 |
Why?
|
Case-Control Studies | 7 | 2019 | 22286 | 0.090 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1669 | 0.080 |
Why?
|
Motor Cortex | 1 | 2017 | 1015 | 0.080 |
Why?
|
Multiprotein Complexes | 2 | 2014 | 1112 | 0.080 |
Why?
|
Ultrasonics | 1 | 2011 | 208 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1885 | 0.080 |
Why?
|
Pain Threshold | 1 | 2013 | 606 | 0.080 |
Why?
|
Motor Skills | 2 | 2015 | 522 | 0.080 |
Why?
|
Glucose Intolerance | 1 | 2013 | 579 | 0.080 |
Why?
|
Lung Neoplasms | 5 | 2019 | 13589 | 0.080 |
Why?
|
Physical Fitness | 2 | 2011 | 744 | 0.080 |
Why?
|
Endoplasmic Reticulum | 1 | 2015 | 1129 | 0.080 |
Why?
|
Morphine | 1 | 2013 | 658 | 0.080 |
Why?
|
Electric Stimulation Therapy | 1 | 2015 | 636 | 0.080 |
Why?
|
Hyperalgesia | 1 | 2013 | 527 | 0.080 |
Why?
|
Obesity | 3 | 2020 | 13065 | 0.080 |
Why?
|
Cystatin B | 1 | 2009 | 13 | 0.080 |
Why?
|
Protein Conformation | 1 | 2017 | 3972 | 0.080 |
Why?
|
Adenoma | 1 | 2020 | 2163 | 0.080 |
Why?
|
Penicillins | 1 | 2012 | 405 | 0.080 |
Why?
|
Phosphorylation | 7 | 2017 | 8331 | 0.080 |
Why?
|
Caenorhabditis elegans | 1 | 2018 | 1462 | 0.080 |
Why?
|
Arm | 2 | 2010 | 590 | 0.080 |
Why?
|
Quinolines | 1 | 2014 | 769 | 0.080 |
Why?
|
Visual Perception | 1 | 2017 | 1406 | 0.080 |
Why?
|
Adenine | 1 | 2014 | 993 | 0.080 |
Why?
|
Narcotic Antagonists | 1 | 2013 | 590 | 0.080 |
Why?
|
Cell Survival | 5 | 2018 | 5800 | 0.080 |
Why?
|
Hypopituitarism | 1 | 2010 | 251 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2015 | 1322 | 0.080 |
Why?
|
Antigens, CD | 2 | 2017 | 4022 | 0.080 |
Why?
|
Adipocytes | 2 | 2020 | 1199 | 0.080 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13709 | 0.080 |
Why?
|
Colonic Polyps | 1 | 2013 | 557 | 0.070 |
Why?
|
China | 1 | 2014 | 2397 | 0.070 |
Why?
|
Young Adult | 11 | 2019 | 60038 | 0.070 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2010 | 435 | 0.070 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2010 | 619 | 0.070 |
Why?
|
Pituitary Gland | 1 | 2010 | 634 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1891 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3832 | 0.070 |
Why?
|
Muscle Spasticity | 1 | 2008 | 158 | 0.070 |
Why?
|
Bone Density | 2 | 2011 | 3561 | 0.070 |
Why?
|
Lymphocytes | 1 | 2015 | 2611 | 0.070 |
Why?
|
Urinary Retention | 1 | 2008 | 106 | 0.070 |
Why?
|
Skull | 1 | 2012 | 832 | 0.070 |
Why?
|
Finasteride | 1 | 2008 | 86 | 0.070 |
Why?
|
Piperazines | 1 | 2018 | 2546 | 0.070 |
Why?
|
Kidney Transplantation | 2 | 2018 | 4285 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2015 | 1894 | 0.070 |
Why?
|
Cisplatin | 4 | 2018 | 1661 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2067 | 0.070 |
Why?
|
Ileum | 1 | 2009 | 558 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1539 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1254 | 0.070 |
Why?
|
Contrast Media | 1 | 2020 | 5337 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2493 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3590 | 0.070 |
Why?
|
Organ Size | 1 | 2011 | 2268 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2014 | 5893 | 0.070 |
Why?
|
Mobility Limitation | 1 | 2010 | 409 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1349 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 937 | 0.070 |
Why?
|
Binding Sites | 1 | 2015 | 6029 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2019 | 2847 | 0.070 |
Why?
|
Plant Extracts | 1 | 2010 | 499 | 0.070 |
Why?
|
Quinazolines | 1 | 2013 | 1376 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 4362 | 0.070 |
Why?
|
Analysis of Variance | 5 | 2018 | 6242 | 0.070 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2243 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2019 | 3038 | 0.070 |
Why?
|
Anthropometry | 1 | 2011 | 1343 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2014 | 20763 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2010 | 2884 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 1 | 2014 | 1277 | 0.060 |
Why?
|
Sirolimus | 1 | 2013 | 1542 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1489 | 0.060 |
Why?
|
United States | 5 | 2019 | 73120 | 0.060 |
Why?
|
Feedback, Physiological | 2 | 2019 | 480 | 0.060 |
Why?
|
Edema | 1 | 2010 | 766 | 0.060 |
Why?
|
Cell Respiration | 2 | 2020 | 201 | 0.060 |
Why?
|
Seizures | 1 | 2018 | 2996 | 0.060 |
Why?
|
19-Iodocholesterol | 1 | 2005 | 1 | 0.060 |
Why?
|
HT29 Cells | 1 | 2005 | 192 | 0.060 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 900 | 0.060 |
Why?
|
Enuresis | 1 | 2005 | 50 | 0.060 |
Why?
|
Afferent Pathways | 2 | 2017 | 304 | 0.060 |
Why?
|
Curcumin | 1 | 2006 | 98 | 0.060 |
Why?
|
Tomography, Optical Coherence | 1 | 2018 | 2958 | 0.060 |
Why?
|
3T3-L1 Cells | 2 | 2020 | 208 | 0.060 |
Why?
|
Mitochondrial Proteins | 1 | 2011 | 979 | 0.060 |
Why?
|
Gene Knockdown Techniques | 3 | 2017 | 1609 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2010 | 1841 | 0.060 |
Why?
|
Up-Regulation | 3 | 2019 | 4132 | 0.060 |
Why?
|
Child | 9 | 2024 | 80856 | 0.060 |
Why?
|
Logistic Models | 3 | 2019 | 13323 | 0.060 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14725 | 0.060 |
Why?
|
Oncolytic Virotherapy | 1 | 2010 | 521 | 0.060 |
Why?
|
Rats | 3 | 2015 | 23839 | 0.060 |
Why?
|
Analgesics, Opioid | 2 | 2013 | 3837 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2015 | 8201 | 0.060 |
Why?
|
Child, Preschool | 8 | 2024 | 42620 | 0.060 |
Why?
|
Catecholamines | 1 | 2005 | 390 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1820 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2020 | 4538 | 0.060 |
Why?
|
Paclitaxel | 2 | 2016 | 1737 | 0.060 |
Why?
|
Adrenal Gland Diseases | 1 | 2005 | 141 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3436 | 0.060 |
Why?
|
Urination Disorders | 1 | 2005 | 238 | 0.060 |
Why?
|
Gene Deletion | 1 | 2011 | 2674 | 0.060 |
Why?
|
Pregnancy Trimester, Second | 1 | 2006 | 738 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3308 | 0.060 |
Why?
|
Epithelial Cells | 3 | 2011 | 3697 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5342 | 0.050 |
Why?
|
Blood Chemical Analysis | 1 | 2005 | 436 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2017 | 3984 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2239 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2019 | 321 | 0.050 |
Why?
|
Computational Biology | 2 | 2019 | 3549 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 2279 | 0.050 |
Why?
|
Drug Synergism | 2 | 2020 | 1765 | 0.050 |
Why?
|
Ultraviolet Rays | 2 | 2019 | 1100 | 0.050 |
Why?
|
Protein Kinases | 1 | 2009 | 1608 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2018 | 1706 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26348 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17637 | 0.050 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2018 | 247 | 0.050 |
Why?
|
Trail Making Test | 1 | 2022 | 57 | 0.050 |
Why?
|
Virus Replication | 1 | 2010 | 2443 | 0.050 |
Why?
|
Odds Ratio | 2 | 2012 | 9687 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7213 | 0.050 |
Why?
|
Cell Division | 1 | 2009 | 4479 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3407 | 0.050 |
Why?
|
Cholesterol | 1 | 2011 | 2910 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2017 | 1444 | 0.050 |
Why?
|
Radiography | 2 | 2020 | 6995 | 0.050 |
Why?
|
Naphthyridines | 2 | 2014 | 184 | 0.050 |
Why?
|
Isoenzymes | 2 | 2020 | 1685 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2019 | 3669 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3901 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2005 | 648 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2396 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 5426 | 0.050 |
Why?
|
Sequence Deletion | 1 | 2005 | 1496 | 0.050 |
Why?
|
RNA Splicing | 2 | 2016 | 906 | 0.050 |
Why?
|
Neurofibromatoses | 1 | 2005 | 300 | 0.050 |
Why?
|
Insulin | 3 | 2013 | 6606 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3734 | 0.050 |
Why?
|
Phantoms, Imaging | 1 | 2010 | 2528 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2010 | 1389 | 0.050 |
Why?
|
Fluorouracil | 2 | 2018 | 1656 | 0.050 |
Why?
|
Patient Care Team | 1 | 2012 | 2526 | 0.050 |
Why?
|
Mice, SCID | 2 | 2017 | 2633 | 0.040 |
Why?
|
Patient Selection | 2 | 2012 | 4266 | 0.040 |
Why?
|
17-Hydroxycorticosteroids | 1 | 2020 | 38 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7602 | 0.040 |
Why?
|
Drug Combinations | 1 | 2006 | 2079 | 0.040 |
Why?
|
Moving and Lifting Patients | 1 | 2020 | 18 | 0.040 |
Why?
|
Adolescent | 7 | 2020 | 89163 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2011 | 2780 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2007 | 1943 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1760 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 22389 | 0.040 |
Why?
|
Transurethral Resection of Prostate | 1 | 2020 | 81 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2020 | 406 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 66 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 617 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11928 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2019 | 224 | 0.040 |
Why?
|
Carcinogenicity Tests | 1 | 2018 | 39 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 682 | 0.040 |
Why?
|
Proteins | 2 | 2010 | 6009 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 239 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2019 | 368 | 0.040 |
Why?
|
Vimentin | 1 | 2018 | 257 | 0.040 |
Why?
|
Colony Count, Microbial | 1 | 2018 | 329 | 0.040 |
Why?
|
Imitative Behavior | 1 | 2017 | 35 | 0.040 |
Why?
|
Nitriles | 2 | 2015 | 984 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2020 | 473 | 0.040 |
Why?
|
Cell Line | 3 | 2018 | 15610 | 0.040 |
Why?
|
Phosphorus | 1 | 2019 | 336 | 0.040 |
Why?
|
Transcriptional Activation | 2 | 2018 | 1751 | 0.040 |
Why?
|
Stroop Test | 1 | 2017 | 72 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2018 | 212 | 0.040 |
Why?
|
Dihydrotestosterone | 1 | 2017 | 195 | 0.040 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2018 | 199 | 0.030 |
Why?
|
Headache | 1 | 2005 | 1260 | 0.030 |
Why?
|
Acute Disease | 2 | 2020 | 7245 | 0.030 |
Why?
|
Inflammation Mediators | 2 | 2020 | 1892 | 0.030 |
Why?
|
Cell Transformation, Viral | 1 | 2018 | 530 | 0.030 |
Why?
|
Allopurinol | 1 | 2018 | 198 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1660 | 0.030 |
Why?
|
Diabetes, Gestational | 1 | 2006 | 1259 | 0.030 |
Why?
|
Kallikreins | 1 | 2018 | 221 | 0.030 |
Why?
|
RNA Probes | 1 | 2016 | 111 | 0.030 |
Why?
|
Functional Laterality | 2 | 2017 | 2268 | 0.030 |
Why?
|
Texas | 1 | 2017 | 405 | 0.030 |
Why?
|
Cytoprotection | 1 | 2017 | 201 | 0.030 |
Why?
|
HLA-A Antigens | 1 | 2016 | 223 | 0.030 |
Why?
|
Protein Stability | 1 | 2018 | 584 | 0.030 |
Why?
|
Integrases | 1 | 2018 | 520 | 0.030 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2016 | 74 | 0.030 |
Why?
|
Thailand | 1 | 2016 | 288 | 0.030 |
Why?
|
Urologic Surgical Procedures | 1 | 2018 | 299 | 0.030 |
Why?
|
Pericytes | 1 | 2018 | 299 | 0.030 |
Why?
|
Bicycling | 1 | 2017 | 178 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8762 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 616 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2019 | 865 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5367 | 0.030 |
Why?
|
Proteoglycans | 1 | 2018 | 807 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2028 | 0.030 |
Why?
|
Social Participation | 1 | 2017 | 185 | 0.030 |
Why?
|
Lung | 1 | 2014 | 10090 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2019 | 771 | 0.030 |
Why?
|
Cell Nucleolus | 1 | 2015 | 156 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7449 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1301 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 671 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2005 | 2586 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2015 | 254 | 0.030 |
Why?
|
Patient Compliance | 1 | 2024 | 2696 | 0.030 |
Why?
|
Femur | 2 | 2011 | 1311 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3710 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 507 | 0.030 |
Why?
|
Gene Expression | 3 | 2015 | 7605 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9623 | 0.030 |
Why?
|
Reference Values | 2 | 2011 | 4941 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1007 | 0.030 |
Why?
|
Qualitative Research | 1 | 2024 | 3115 | 0.030 |
Why?
|
Genotype | 2 | 2019 | 13045 | 0.030 |
Why?
|
Quality of Life | 2 | 2017 | 13497 | 0.030 |
Why?
|
Chronic Disease | 3 | 2015 | 9379 | 0.030 |
Why?
|
Desmin | 1 | 2013 | 99 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1840 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 614 | 0.030 |
Why?
|
National Health Programs | 1 | 2016 | 442 | 0.030 |
Why?
|
Resorcinols | 1 | 2013 | 41 | 0.030 |
Why?
|
Antigens | 1 | 2018 | 1443 | 0.030 |
Why?
|
Malondialdehyde | 1 | 2013 | 113 | 0.030 |
Why?
|
Injections, Spinal | 1 | 2013 | 318 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2013 | 127 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1104 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12242 | 0.030 |
Why?
|
Breath Tests | 1 | 2014 | 300 | 0.030 |
Why?
|
Anions | 1 | 2012 | 138 | 0.030 |
Why?
|
Cytochromes c | 1 | 2013 | 173 | 0.030 |
Why?
|
Mice, Inbred ICR | 1 | 2013 | 363 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10784 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2006 | 12450 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1077 | 0.030 |
Why?
|
Caregivers | 1 | 2024 | 2302 | 0.030 |
Why?
|
Video Recording | 1 | 2017 | 974 | 0.020 |
Why?
|
Doxorubicin | 1 | 2019 | 2229 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 598 | 0.020 |
Why?
|
Cations | 1 | 2012 | 240 | 0.020 |
Why?
|
Static Electricity | 1 | 2012 | 261 | 0.020 |
Why?
|
Fatty Acids | 1 | 2020 | 1818 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 856 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1364 | 0.020 |
Why?
|
Triage | 1 | 2018 | 997 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2013 | 348 | 0.020 |
Why?
|
Limit of Detection | 1 | 2012 | 277 | 0.020 |
Why?
|
Research Design | 2 | 2017 | 6217 | 0.020 |
Why?
|
DNA, Viral | 1 | 2018 | 2203 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2011 | 5891 | 0.020 |
Why?
|
Occupational Diseases | 1 | 2020 | 1494 | 0.020 |
Why?
|
Isoxazoles | 1 | 2013 | 233 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1898 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2013 | 577 | 0.020 |
Why?
|
Lumbar Vertebrae | 2 | 2011 | 1885 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1614 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2017 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2013 | 427 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2018 | 986 | 0.020 |
Why?
|
Lipoxins | 1 | 2014 | 419 | 0.020 |
Why?
|
Hemiplegia | 1 | 2011 | 136 | 0.020 |
Why?
|
Marital Status | 1 | 2012 | 426 | 0.020 |
Why?
|
Metabolome | 1 | 2018 | 1009 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2014 | 660 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1650 | 0.020 |
Why?
|
Nitrobenzenes | 1 | 2010 | 66 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3164 | 0.020 |
Why?
|
Egtazic Acid | 1 | 2010 | 166 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 107 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2011 | 199 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 423 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 2082 | 0.020 |
Why?
|
Ribonucleotide Reductases | 1 | 2010 | 75 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 2013 | 628 | 0.020 |
Why?
|
Referral and Consultation | 2 | 2013 | 3629 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2010 | 136 | 0.020 |
Why?
|
Caspases | 1 | 2013 | 884 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1381 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 861 | 0.020 |
Why?
|
Cyclin B | 1 | 2009 | 104 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3615 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2013 | 1891 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 868 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1794 | 0.020 |
Why?
|
Microscopy | 1 | 2014 | 909 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1409 | 0.020 |
Why?
|
Seasons | 1 | 2015 | 1526 | 0.020 |
Why?
|
Multifactorial Inheritance | 1 | 2017 | 1421 | 0.020 |
Why?
|
Protein Kinase C-alpha | 1 | 2009 | 113 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2013 | 679 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6353 | 0.020 |
Why?
|
Calcaneus | 1 | 2010 | 143 | 0.020 |
Why?
|
Antioxidants | 1 | 2017 | 1678 | 0.020 |
Why?
|
CDC2 Protein Kinase | 1 | 2009 | 212 | 0.020 |
Why?
|
Tissue Donors | 1 | 2018 | 2377 | 0.020 |
Why?
|
Chelating Agents | 1 | 2010 | 385 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2009 | 826 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2622 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 414 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2431 | 0.020 |
Why?
|
Muscles | 1 | 2013 | 1582 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5490 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2013 | 1192 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1884 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2010 | 796 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 1977 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 939 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2012 | 2488 | 0.020 |
Why?
|
Arsenic | 1 | 2011 | 362 | 0.020 |
Why?
|
Cyclin D | 1 | 2007 | 72 | 0.020 |
Why?
|
Mouth Mucosa | 1 | 2010 | 437 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2038 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2007 | 130 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2896 | 0.020 |
Why?
|
Fatty Liver | 1 | 2013 | 807 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2009 | 399 | 0.020 |
Why?
|
Reaction Time | 1 | 2013 | 2102 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2009 | 15879 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1969 | 0.020 |
Why?
|
Intestine, Small | 1 | 2013 | 1218 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 699 | 0.020 |
Why?
|
Prospective Studies | 3 | 2018 | 54913 | 0.020 |
Why?
|
Herpes Simplex | 1 | 2010 | 470 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2009 | 444 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2013 | 2925 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1409 | 0.020 |
Why?
|
CpG Islands | 1 | 2011 | 1211 | 0.020 |
Why?
|
Lasers | 1 | 2010 | 952 | 0.020 |
Why?
|
Neuropeptides | 1 | 2011 | 950 | 0.020 |
Why?
|
DNA Damage | 1 | 2015 | 2461 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 1882 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36496 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 952 | 0.020 |
Why?
|
Exercise | 1 | 2022 | 5940 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2007 | 384 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2018 | 3077 | 0.020 |
Why?
|
Treatment Failure | 1 | 2011 | 2655 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4622 | 0.010 |
Why?
|
Pregnancy | 1 | 2006 | 30179 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 639 | 0.010 |
Why?
|
Algorithms | 1 | 2005 | 14157 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 998 | 0.010 |
Why?
|
Luciferases | 1 | 2006 | 712 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2010 | 1749 | 0.010 |
Why?
|
Body Height | 1 | 2010 | 1568 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14483 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 2046 | 0.010 |
Why?
|
Length of Stay | 1 | 2018 | 6521 | 0.010 |
Why?
|
Single-Cell Analysis | 1 | 2015 | 2531 | 0.010 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2006 | 720 | 0.010 |
Why?
|
Spin Labels | 1 | 2005 | 339 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3234 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5308 | 0.010 |
Why?
|
HeLa Cells | 1 | 2009 | 3091 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2013 | 2072 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4534 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4120 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15879 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2009 | 2730 | 0.010 |
Why?
|
RNA, Nuclear | 1 | 2002 | 29 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2006 | 1524 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8372 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2009 | 1628 | 0.010 |
Why?
|
Aspirin | 1 | 2014 | 3139 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3047 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 711 | 0.010 |
Why?
|
Retinoblastoma Protein | 1 | 2005 | 674 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10269 | 0.010 |
Why?
|
Epilepsy | 1 | 2016 | 3324 | 0.010 |
Why?
|
Drug Design | 1 | 2006 | 1050 | 0.010 |
Why?
|
Keratins | 1 | 2002 | 502 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2785 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5808 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3074 | 0.010 |
Why?
|
Software | 1 | 2014 | 4465 | 0.010 |
Why?
|
Sulfonamides | 1 | 2010 | 1988 | 0.010 |
Why?
|
Molecular Weight | 1 | 2002 | 2173 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2002 | 903 | 0.010 |
Why?
|
Epithelium | 1 | 2004 | 1610 | 0.010 |
Why?
|
Postoperative Period | 1 | 2005 | 1833 | 0.010 |
Why?
|
Protons | 1 | 2005 | 1112 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12771 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16023 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26394 | 0.010 |
Why?
|
Pyridines | 1 | 2010 | 2888 | 0.010 |
Why?
|
Brain | 1 | 2005 | 27439 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10601 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1629 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8051 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5709 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2002 | 1081 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2003 | 1496 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3793 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10845 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22365 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4984 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18047 | 0.010 |
Why?
|
RNA, Viral | 1 | 2002 | 2854 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2002 | 3472 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 9066 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 9261 | 0.000 |
Why?
|